奥氮平与碳酸锂对双相情感障碍患者躁狂症状、血清尿酸水平的影响及安全性比较

The effect of olanzapine on manic symptoms and serum uric acid level of patients with bipolar disorder

ES评分 0

DOI
刊名
Journal of International Psychiatry
年,卷(期) 2018, 45(4)
作者
作者单位

驻马店市第二人民医院精神四科 ;
驻马店第二人民医院 ;

摘要
【摘要】比较奥氮平与碳酸锂对双相情感障碍躁狂发作患者症状、血清尿酸水平的影响及安全性。方法 对我院治疗的72例双相情感障碍躁狂发作患者进行研究。将患者分为观察组、对照组,比较两组患者治疗前后的Beck-Rafaelsen躁狂量表(BRMS)评分、血清尿酸水平以及不良反应发生情况。结果 两组患者治疗后,BRMS评分较治疗前均有显著降低(P<0.05),且观察组患者各时间段的BRMS评分均显著低于对照组各时间段的BRMS评分(P<0.05)。两组患者治疗前后及各时间点的血清尿酸水平比较差异均无统计学意义(P>0.05)。对两组患者随访8周,对照组的不良反应发生率与观察组相比无显著差异(P>0.05)。结论 奥氮平治疗双相情感障碍躁狂发作的疗效确切,安全性较高。但是,本研究未发现其对血清尿酸水平的显著影响。
Abstract
【Abstract】Objective To explore the effect of olanzapine on manic symptoms and serum uric acid level of patients with bipolar disorder. Methods 72 bipolar disorder patients with manic symptoms in our hospital were studied. The patients were randomly divided into the observation group and the control group. Beck-Rafaelsen mania score (BRMS) score, serum uric acid level and the incidence of adverse reactions of both groups were collected and compared between the two groups before and after treatment. Results After treatment, both groups showed statistically reduction in BRMS score (P<0.05), and the observation group had statistically lower score than the control group at any point-in-time (P<0.05). There was no significant difference in the serum uric acid level between the two groups before and after treatment and at any point-in-time (P>0.05). The two groups of patients were followed for 8 weeks, and no significant difference showed in terms of adverse reaction (P>0.05). Conclusion Olanzapine has obvious curative effect and high safety in the treatment of bipolar disorder. However, we have not found its significant impact on serum uric acid level in this research.
关键词
【关键词】奥氮平;双相情感障碍;躁狂;血清尿酸
KeyWord
【Keywords】Olanzapine; Bipolar disorder; Mania; Serum uric acid
基金项目
页码 655-657
  • 参考文献
  • 相关文献
  • 引用本文

贡永宁*,王冲,孙连锋,胡亚凯. 奥氮平与碳酸锂对双相情感障碍患者躁狂症状、血清尿酸水平的影响及安全性比较 [J]. 国际精神病学杂志. 2018; 45; (4). 655 - 657.

  • 文献评论

相关学者

相关机构